-
1
Chinese patent medicine tongxinluo capsule as a supplement to treat chronic coronary syndromes: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials
Published 2025-01-01Subjects: “…chronic coronary syndromes…”
Get full text
Article -
2
A smartphone-guided secondary prevention digital health application reduces systolic blood pressure in patients with chronic coronary syndrome and insufficient blood pressure contr...
Published 2025-02-01Subjects: “…chronic coronary syndrome…”
Get full text
Article -
3
-
4
-
5
Diffuseness of coronary artery disease impacts on immediate hemodynamic and predicted clinical outcomes
Published 2025-01-01Subjects: Get full text
Article -
6